Surgical polypropylene mesh market to reach $3.29 billion by 2030

The surgical polypropylene mesh market is forecast to keep expanding through 2030 as hernia cases rise, surgery volumes increase and hospitals adopt more advanced mesh materials. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Surgical polypropylene mesh is used to reinforce weakened tissue during surgery, making it a core product in hernia and pelvic repair procedures. - Rising hernia rates and broader use of minimally invasive surgery are expanding demand for the device. - The market outlook points to continued growth in hospital spending, mesh innovation and surgical capacity.

What happened: - The Business Research Company released a 2026 report on the global surgical polypropylene mesh market. - The market size rose from $2.44 billion in 2025 to an estimated $2.6 billion in 2026. - The report projects the market will reach $3.29 billion by 2030. - The report was published Aug. 31, 2026. - Download a free sample of the report. - View the full market report.

The details: - The market grew at a CAGR of 6.6% from 2025 to 2026. - The report forecasts a 6.1% CAGR from 2026 to 2030. - Growth in the recent period was linked to more hernia and pelvic disorder cases, increased surgical procedures, advances in synthetic mesh materials, greater awareness of post-surgical complications and wider use of minimally invasive surgery. - Future growth is tied to mesh coating technology, smart manufacturing, healthcare infrastructure growth in developing regions, demand for customized mesh products, and a larger elderly population with more chronic illness. - The report highlights a stronger focus on minimally invasive surgeries, biocompatible materials, elective surgeries, tailored mesh designs and investment in healthcare facilities. - Surgical polypropylene mesh is a non-absorbable synthetic device made from polypropylene, a durable plastic polymer. - The mesh is designed to be biocompatible, porous and able to support tissue growth through the implant. - Hernia cases in the U.S. are projected to rise from 2,764,122 in 2022 to 3,309,718 by 2050, a 19.7% increase, according to National Institutes of Health data cited in the report. - North America held the largest share of the global market in 2025. - Asia-Pacific is projected to grow the fastest over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The forecast suggests demand is being driven by both procedural volume and product improvement, not just by disease prevalence. - North America’s lead likely reflects mature healthcare infrastructure, while Asia-Pacific’s growth points to expanding access and rising surgery capacity. - The inclusion of TAM analysis and forecasting dashboards signals that buyers are looking for more granular investment and competitive planning tools.

What's next: - The market is expected to keep expanding through 2030 as aging populations, chronic disease burden and surgical innovation support demand. - Companies targeting this segment will likely focus on coating technology, customization and manufacturing efficiency. - Regional growth should remain uneven, with Asia-Pacific gaining share faster than established markets.